Craig-Hallum Starts LB Pharmaceuticals Inc (LBRX) at Buy, 'A Schizophrenia-Driven Story With Long-Term Mood Optionality'
Tweet Send to a Friend
Craig-Hallum analyst Adam Vogel initiates coverage on LB Pharmaceuticals Inc (NASDAQ: LBRX) with a Buy rating and a price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
